Fundraising Fox
/Investor DB
Sign in

Vast Ventures — 2014 Investments

1 investments dated 2014 · listed companies and verified rows first · show all

Recombinerecombine.comMar 2014 · $3.3MAcquired

Recombine was a New York-based clinical genetics company offering expanded carrier screening (CarrierMap) and non-invasive prenatal testing (ChromoMap) to assess genetic and chromosomal risks for prospective parents.

New York, US

Alexander Bisignano(Executive Officer, Director)

BoardMathias Turck(Director)Santiago Munne(Director)in

Co-investorsFirstMark CapitalNat Turner

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.